4-[4-(4-Fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-3-yl]-1-methyl­pyridinium iodide–4-[3-(4-fluoro­phen­yl)-2-methyl-5-oxo-2,5-dihydro­isoxazol-4-yl]-1-methyl­pyridinium iodide (0.6/0.4)

The crystal structure of the title compound, C(16)H(16)FN(2)O(2) (+)·I(−), was determined as part of a study of the biological activity of isoxazolone derivatives as p38 mitogen-activated protein kinase (MAPK) inhibitors. The X-ray crystal structure of 4-[4-(4-fluoro­phenyl)-2-methyl-5-oxo-2,5-dihyd...

Descripción completa

Detalles Bibliográficos
Autores principales: Margutti, Simona, Schollmeyer, Dieter, Laufer, Stefan
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2007
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915348/
https://www.ncbi.nlm.nih.gov/pubmed/21200862
http://dx.doi.org/10.1107/S1600536807055985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915348/
https://www.ncbi.nlm.nih.gov/pubmed/21200862
http://dx.doi.org/10.1107/S1600536807055985

Ejemplares similares